英文别名：
Scopolamine hydrobromide;Hyoscine hydrobromide;(-)-Scopolamine hydrobromide trihydrate;(1S,2R)-9-Methyl-3-oxa-9- azatricyclo[3.3.1.0 {2,4}]nonan-7-yl- (2S)-3-hydroxy-2-phenylpropanoate trihydrate hydrobromide;(S)-(1R,2R,4S,5S,7s)-9-Methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl 3-hydroxy-2-phenylpropanoate hydrobromide;(-)-Scopolamine hydrobromide;beldavrin;euscopol;HYOSCINE;Hyoscine bromide;Hyosol;hysco;kwells;scopamin;Scopine hydrobromide;Scopolamine HBr;Scopolamine Hydrobromide Trihydrate;scopos;sereen;triptone;1aH,5aH-Tropan-3a-ol, 6b,7b-epoxy-, (-)-tropate (ester), hydrobromide (8CI);Benzeneacetic acid, a-(hydroxymethyl)-, (1a,2b,4b,5a,7b)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-ylester, hydrobromide, (aS)- (9CI);Benzeneacetic acid, a-(hydroxymethyl)-, 9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-ylester, hydrobromide, [7(S)-(1a,2b,4b,5a,7b)]-;Scopolamine bromide (6CI);3-Oxa-9-azatricyclo[3.3.1.02,4]nonane, benzeneacetic acid deriv.;(-)-Hyoscinehydrobromide;(-)-Scopolamine bromide;Hydroscine hydrobromide;Hyocine F hydrobromide;Isoscopil;Scopolaminium bromide;Scopolammonium bromide;Sea Legs;Wellcome Brand Scopolamine hydrobromide Injection;l-Hyoscinehydrobromide;l-Scopolamine hydrobromide;Tranaxine;Scopolaminehydrobromide;Scopolamine (hydrobromide);(-)-Hyoscine hydrobromide;R3K67DRL3J;MLS000069527;SCOPOLAMINE BROMIDE;l-Hyoscine hydrobromide;SMR000058594;l-Scopolamine-hydrobromide;DSSTox_RID_78902;DSSTox_CID_12029;DSSTox_GSID_320;AB00429689_32;[(1R,2R,4S,5S)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl] (2S)-3-hydroxy-2-phenylpropanoate;levo-duboisine;OW0;SCOPOLAMINE [MI];CHEMBL3084722;HYOSCINE [WHO-DD];(1R,2R,4S,5S,7S)-9-methyl-3-oxa-9-azatricyclo[3.3.1.0^{2,4}]nonan-7-yl (2S)-3-hydroxy-2-phenylpropanoate;S-(-)-Tropate;HYOSCINE [MART.];Hyosceine;BSPBio_000953;6-beta,7-beta-Epoxy-3-alpha-tropanyl S-(-)-tropate;Scopolamine 100 microg/mL in Acetonitrile;SCHEMBL16226;Transcop;s9326;Hyoscyine hydrobromide;Scopolamine HCl;(1R,2R,4S,5S,7S)-9-methyl-3-oxa-9-azatricyclo[3.3.1.0~2,4~]non-7-yl (2S)-3-hydroxy-2-phenylpropanoate;scopolamine;Benzeneacetic acid, alpha-(hydroxymethyl)-, 9-methyl-3-oxa-9-azatricyclo(3.3.1.02,4)non-7-yl ester, (7(S)-(1alpha,2beta,4beta,5alpha,7beta))-;(1R,2R,4S,5S,7S)-9-methyl-3-oxa-9-azatricyclo[3.3.1.0(2,4)]non-7-yl (2S)-3-hydroxy-2-phenylpropanoate;BPBio1_001049;BRD-K89923877-003-02-4;NCGC00024357-04;l-Scopolamine;(1S,3S,5R,6R,7S)-6,7-epoxytropan-3-yl (2S)-3-hydroxy-2-phenylpropanoate;HYOSCINE [EP IMPURITY];ATROPINE SULFATE IMPURITY F [EP IMPURITY];SCOPOLAMINE [HSDB];STECJAGHUSJQJN-USLFZFAMSA-N;HMS3886L22;SCHEMBL22393238;BDBM50263508;Epoxytropine tropate;CS-6609;AC-968;HY-N0296;Skopolamin;HYOSCINE [EP MONOGRAPH];(+)-Hyoscine;51-34-3;HSDB 4074;HMS2090N13;Prestwick3_000877;SCOPOLAMINE [USP IMPURITY];alpha-(Hydroxymethyl)benzeneacetic acid 9-methyl-3-oxa-9-azatricyclo(3.3.1.0(2.4))non-7-yl ester;(methyl[?]yl) (2S)-3-hydroxy-2-phenyl-propanoate;SCOPOLAMINE [ORANGE BOOK];SCOPOLAMINE [VANDF];Scopine (-)-tropate;CHEBI:93572;1ST10286;EN300-1718536;(1R,2R,4S,5S,7R)-9-methyl-3-oxa-9-azatricyclo[3.3.1.0,2,4]nonan-7-yl (2S)-3-hydroxy-2-phenylpropanoate;6beta,7beta-Epoxy-1alpha,5alpha-tropan-3alpha-ol;CCG-267504;BENZENEACETIC ACID, .ALPHA.-(HYDROXYMETHYL)-, 9-METHYL-3-OXA-9-AZATRICYCLO(3.3.1.02,4)NON-7-YL ESTER, (7(S)-(1.ALPHA.,2.BETA.,4.BETA.,5.ALPHA.,7.BETA.))-;(1R,2R,4S,5S,7R)-9-methyl-3-oxa-9-azatricyclo[3.3.1.0,nonan-7-yl (2S)-3-hydroxy-2-phenylpropanoate;EINECS 200-090-3;Boro-Scopol;1alphaH,5alphaH-Tropan-3alpha-ol, 6beta,7beta-epoxy-, (-)-tropate (ester);AB00429689-30;Benzeneacetic acid, alpha-(hydroxymethyl)-, (1alpha,2beta,4beta,5alpha,7beta)-9-methyl-3-oxa-9-azatricyclo(3.3.1.02,4)non-7-yl ester, (alphaS)-;SMP1_000270;UNII-DL48G20X8X;NCGC00024357-05;(1R,2R,4S,5S,7s)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl (2S)-3-hydroxy-2-phenylpropanoate;DL48G20X8X;AKOS025402477;Tropic acid, 9-methyl-3-oxa-9-azatricyclo(3.3.1.0(sup 2,4))non-7-yl ester;(1R,2R,4S,5S,7S)-9-METHYL-3-OXA-9-AZATRICYCLO(3.3.1.02,4)NON-7-YL (2S)-3-HYDROXY-2-PHENYLPROPANOATE;AB00429689-31;Q337188;Isopto Hyoscine;DTXSID6023573;BENZENEACETIC ACID, .ALPHA.(HYDROXYMETHYL)-,(1.ALPHA.,2.BETA.,4.BETA.,5.ALPHA.,7.BETA.)-9-METHYL-3-OXA-9-AZATRICYCLO(3.3.1.02,4)NON-7-YL ESTER, (.ALPHA.S)-;hydrobromicum, Scopolaminum;3-Oxa-9-azatricyclo(3.3.1.0(sup 2,4))nonan-7-ol, 9-methyl-, tropate (ester);Atroquin;Scopoderm;Transderm scop;EC 200-090-3;Q27165268;CHEMBL1906925;CHEBI:16794;Scopine tropate;6beta,7beta-Epoxy-3alpha-tropanyl S-(-)-tropate;Scop;CHEMBL569713;Tropane alkaloid;Scopace;LSM-4015;[7(S)-(1.alpha.,2.beta.,4.beta.,5.alpha.,7.beta.)]-.alpha.-(Hydroxymethyl)benzeneacetic acid 9-methyl-3-oxa-9-azatricyclo-[3.3.1.0^2,4]non-7-yl ester;SEE;GTPL330;6,7-Epoxytropine tropate;NSC61806;3-Oxa-9-azatricyclo(3.3.1.O(sup 2,4))nonan-7-ol, 9-methyl-, tropate (ester);DB00747;(1R,2R,4S,5S,7s)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl (S)-3-hydroxy-2-phenylpropanoate;(-)-Hyoscine;Scopolamine dried down 100 microg/mL;Tropic acid, ester with scopine;(1R,2R,4S,5S,7s)-9-Methyl-3-oxa-9-azatricyclo[3.3.1.0~2,4~]nonan-7-yl (2S)-3-hydroxy-2-phenylpropanoate;AB00429689;(-)-Scopolamin (Hyoscine);(-)-Scopolamine;(1R,2R,4S,5S,7S)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl (2R)-3-hydroxy-2-phenylpropanoate;Transderm-Scop;Atrochin;6.beta.,7.beta.-Epoxy-1.alpha.H,5.alpha.H-tropan-3.alpha.-ol (-)-tropate (ester);SW199343-2;CAS-114-49-8;SR-01000597758-1;AKOS015965267;6.BETA.,7.BETA.-EPOXY-1.ALPHA.H,5.ALPHA.H-TROPAN-3.ALPHA.-OL (-)-TROPATE (ESTER) HYDROBROMIDE;SCOPOLAMINE HYDROBROMIDE [MI];1alphaH,5alphaH-Tropan-3-alpha-ol, 5beta,7beta-epoxy-, (-)-tropate (ester), hydrobromide;NSC 61806;Opera_ID_496;REGID_for_CID_6603108;CHEBI:61271;scopolammonium bromide (anhydrous);(1R,2R,4S,5S)-9-methyl-3-oxa-9-azatricyclo[3.3.1.0(2),?]nonan-7-yl (2S)-3-hydroxy-2-phenylpropanoate hydrobromide;Q27130957;scopolaminium bromide (anhydrous);NSC-61806;(1R,2R,4S,5S,7s,9s)-7-{[(2S)-3-hydroxy-2-phenylpropanoyl]oxy}-9-methyl-3-oxa-9-azoniatricyclo[3.3.1.0(2,4)]nonane bromide;CHEMBL3185877;s2508;CCG-268451;(-)-Scopolamine hydrobromide;Hyoscine hydrobromide;Scopine hydrobromide;1ST10750;Scopolamine hydrobromide anhydrous;Benzeneacetic acid, alpha-(hydroxymethyl)-, (1alpha,2beta,4beta,5alpha,7beta)-9-methyl-3-oxa-9-azatricyclo(3.3.1.02,4)non-7-yl ester, hydrobromide (1:1), (alphaS)-;PD087159;NCGC00024357-07;[(1S,2S,4R,5R)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl] (2S)-3-hydroxy-2-phenylpropanoate;hydrobromide;Benzeneacetic acid, alpha-(hydroxymethyl)-, (1alpha,2beta,4beta,5alpha,7beta)-9-methyl-3-oxa-9-azatricyclo(3.3.1.02,4)non-7-yl ester, hydrobromide, (alphaS)-;UNII-R3K67DRL3J;NCGC00255166-01;AC-3389;(-)-scopolamine bromide (anhydrous);(-)-scopolamine hydrobromide (anhydrous);(-)-hyoscine hydrobromide (anhydrous);Benzeneacetic acid, alpha-(hydroxymethyl)-, 9-methyl-3-oxa-9-azatricyclo(3.3.1.02,4)non-7-yl ester, hydrobromide, (7(S)-(1alpha,2beta,4beta,5alpha,7beta))-;(1R,2R,4S,5S,7S)-9-methyl-3-oxa-9-azatricyclo[3.3.1.0(2,4)]non-7-yl (2S)-3-hydroxy-2-phenylpropanoate hydrobromide;Tox21_110035_1;HYOSCINE HYDROBROMIDE [WHO-DD];114-49-8;Scopolamine Hydrobromide (anhydrous);DTXCID8012029;Tox21_302019;A935283;DTXSID0032029;Tox21_110035;HY-N0296A;SCHEMBL40627;NS00076152;Benzeneacetic acid, .alpha.-(hydroxymethyl)-, (1.alpha.,2.beta.,4.beta.,5.alpha.,7.beta.)-9-methyl-3-oxa-9-azatricyclo3.3.1.02,4non-7-yl ester, (.alpha.S)- hydrobromide;SR-01000597758;WTGQALLALWYDJH-MOUKNHLCSA-N;1alphaH,5alphaH-Tropan-3alpha-ol, 6beta,7beta-epoxy-, (-)-tropate (ester), hydrobromide;AS-35324;1-alpha-H,5-alpha-H-Tropan-3-alpha-ol, 6-beta,7-beta-epoxy-, (-)-tropate (ester), hydrobromide;NCGC00013722-01;hyoscine bromide (anhydrous);scopolamine bromide (anhydrous);W-108599;EC 204-050-6;EINECS 204-050-6;CS-2000;
522593521 
![3-氧杂-9-偶氮三环[3.3.1.02,4]壬烷，7-[（2S）-3-羟基-1-氧代-2-苯丙氧基]-9,9-二甲基-（1a，2b，4b，5a，7b）-](http://hg.y866.cn/compound/lib/scimg/cas/150/13265-10-6.png "3-氧杂-9-偶氮三环[3.3.1.02,4]壬烷，7-[（2S）-3-羟基-1-氧代-2-苯丙氧基]-9,9-二甲基-（1a，2b，4b，5a，7b）-")
